BerGenBio Announces First Patient Entered Into Advanced Adenocarcinoma Lung Cancer Trial By Investing.com

BerGenBio Announces First Patient Entered Into Advanced Adenocarcinoma Lung Cancer

BERGEN, Norway, Jan. 7, 2025 /PRNewswire/ —  BerGenBio ASA (OSE: BGBIO), a clinical-stage…

www.investing.com